What Is GRB10? Biology and Molecular Background

GRB10 (Growth Factor Receptor-Bound Protein 10) is an intracellular adaptor protein belonging to the GRB7/GRB10/GRB14 family. These proteins share a conserved domain architecture that enables them to interact with activated receptor tyrosine kinases (RTKs) and modulate downstream signaling cascades.

The human GRB10 gene is located on chromosome 7p12 and is subject to genomic imprinting, with expression predominantly from the maternal allele in most tissues and from the paternal allele in the brain. This imprinting pattern underscores the importance of precise GRB10 dosage in development and metabolism.

Structurally, GRB10 contains several functional modules: an N-terminal proline-rich region, a central pleckstrin homology (PH) domain, a BPS (Between PH and SH2) domain unique to this protein family, and a C-terminal Src Homology 2 (SH2) domain. The BPS and SH2 domains cooperate to bind the activated, phosphorylated kinase domains of the insulin receptor (IR) and IGF-1 receptor (IGF1R), placing GRB10 as a direct regulator of these critical metabolic and mitogenic pathways.

GRB10 Signaling Mechanisms and Pathway Interactions

GRB10 functions primarily as a negative regulator of insulin and IGF-1 receptor signaling. Upon receptor activation, GRB10 is recruited to phosphorylated tyrosine residues in the kinase activation loop of IR and IGF1R through its BPS-SH2 domain tandem. This interaction sterically hinders substrate access and attenuates downstream signal propagation through the PI3K/AKT and MAPK/ERK pathways.

A pivotal aspect of GRB10 regulation is its phosphorylation by mTORC1 (mechanistic target of rapamycin complex 1). mTORC1-mediated phosphorylation of GRB10 on serine residues stabilizes the protein, which in turn provides negative feedback to the PI3K/AKT pathway. This feedback loop positions GRB10 as a critical node linking nutrient sensing, growth factor signaling, and cellular metabolism.

GRB10 also interacts with other signaling partners including NEDD4 (an E3 ubiquitin ligase that targets GRB10 for degradation), Raf kinase, and the proto-oncogene product RETEN (RET). These interactions expand its regulatory influence beyond classical insulin signaling into proliferation, differentiation, and apoptotic pathways, making GRB10 a multifunctional adaptor of broad biological significance.

Research Applications of Recombinant Human GRB10 Protein

Recombinant Human GRB10 Protein (SKU: rp371613) is a valuable reagent for a wide range of in vitro and cell-based research applications. Key uses include:

• Protein–protein interaction studies: GRB10 can be used in pull-down assays, co-immunoprecipitation controls, and surface plasmon resonance (SPR) experiments to map binding interfaces with IR, IGF1R, mTOR complex components, and other interacting partners.
• Enzyme activity and inhibition assays: Recombinant GRB10 can serve as a substrate or competitive inhibitor in kinase assays designed to evaluate receptor tyrosine kinase activity and screen for small-molecule modulators.
• Structural biology: High-purity recombinant protein is suitable for crystallography, cryo-EM, or NMR studies aimed at resolving GRB10 domain structures and interaction complexes.
• Antibody development and validation: The recombinant protein serves as an immunogen or positive control for generating and validating anti-GRB10 antibodies.
• Metabolic and oncology research: GRB10 is relevant to type 2 diabetes, obesity, Silver–Russell syndrome, and multiple cancers. Recombinant protein enables mechanistic dissection of GRB10's role in disease-relevant signaling contexts.

Handling, Storage, and Quality Considerations

To maintain the activity and integrity of Recombinant Human GRB10 Protein, researchers should adhere to the following best practices:

• Storage: Store lyophilized or liquid formulations according to the manufacturer's certificate of analysis (CoA). Typically, proteins are stored at −20 °C or −80 °C to prevent degradation. Avoid repeated freeze–thaw cycles by preparing single-use aliquots upon first reconstitution.
• Reconstitution: Reconstitute lyophilized protein in sterile, deionized water or the recommended buffer as specified in the product CoA. Allow the vial to equilibrate to room temperature before opening to minimize condensation-related contamination.
• Carrier protein: If working at very low protein concentrations, consider adding BSA (0.1% final concentration) to prevent adsorptive losses to tube and plate surfaces.
• Quality control: Lot-specific purity and activity data should be obtained from the CoA provided with each shipment. SDS-PAGE and Western blot confirmation are recommended prior to critical experiments.
• Biosafety: Handle according to institutional biosafety guidelines. Although recombinant proteins are generally low-risk, standard laboratory precautions (gloves, eye protection, proper waste disposal) apply.